BioCrude Technologies USA, Inc.: net property, plant and equipment
Net property, plant and equipment for BioCrude Technologies USA, Inc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All BioCrude Technologies USA, Inc. financial histories
What this measure means
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
Exact concept: us-gaap:PropertyPlantAndEquipmentNet. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2018-12-31 to 2025-12-31. The SEC response was captured on 2026-09-21.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-12-31 | 9,037 | USD | 2026-03-27 | 10-K · 0001731122-26-000496 |
| At date | 2024-12-31 | 13,890 | USD | 2026-03-27 | 10-K · 0001731122-26-000496 |
| At date | 2023-12-31 | 15,933 | USD | 2025-03-27 | 10-K · 0001731122-25-000459 |
| At date | 2022-12-31 | 17,895 | USD | 2024-03-27 | 10-K · 0001731122-24-000503 |
| At date | 2021-12-31 | 20,854 | USD | 2023-03-29 | 10-K · 0001731122-23-000488 |
| At date | 2020-12-31 | 19,697 | USD | 2022-03-23 | 10-K · 0001731122-22-000498 |
| At date | 2019-12-31 | 23,752 | USD | 2021-02-12 | 10-K · 0001731122-21-000226 |
| At date | 2018-12-31 | 27,145 | USD | 2020-03-20 | 10-K · 0001731122-20-000283 |
Related financial histories
- BioCrude Technologies USA, Inc.: total assets
- BioCrude Technologies USA, Inc.: total liabilities
- BioCrude Technologies USA, Inc.: stockholders equity
- BioCrude Technologies USA, Inc.: cash and cash equivalents
- BioCrude Technologies USA, Inc.: net income or loss
- BioCrude Technologies USA, Inc.: operating cash flow
- BioCrude Technologies USA, Inc.: capital expenditure payments
- BioCrude Technologies USA, Inc.: financing cash flow
- BioCrude Technologies USA, Inc.: investing cash flow
- BioCrude Technologies USA, Inc.: retained earnings or deficit
- BioCrude Technologies USA, Inc.: basic weighted-average shares
- BioCrude Technologies USA, Inc.: diluted weighted-average shares
- BioCrude Technologies USA, Inc.: basic earnings per share
- BioCrude Technologies USA, Inc.: diluted earnings per share
- BioCrude Technologies USA, Inc.: operating income or loss
- BioCrude Technologies USA, Inc.: current assets
- BioCrude Technologies USA, Inc.: interest expense
- BioCrude Technologies USA, Inc.: current liabilities
Inspect the source
- Entity
- BioCrude Technologies USA, Inc. / CIK 0001690384
- Captured
- 2026-09-21T17:24:05.073Z
- SEC response SHA-256
89c76d3d401fe6afb068748f997c9daeba79c1147b3d9c59f4ddc55dd1617a16
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001690384.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))